CanAg ProGRP EIA [CE]

TheCanAg ProGRP EIAkit assay is to be used as an aid in the differential diagnosis and in monitoring disease progession during the course of disease and treatment in smallcell lung cancer patients TheCanAg ProGRP EIAis a solid-phase, one-step, non-competitive immunoassay based on antibodies specific for different epitopes specifically expressed in ProGRP. Calibrators, controls or unknown samples are incubated together with affinity purified biotinylated Anti-ProGRP polyclonal antibody and horser